The Specialization Mandate: Focusing on Oncology, CNS, and Complex Therapeutics in the US CRO Sector
A defining trend in the US contract research sector is the increasing demand for specialized therapeutic expertise, particularly in high-growth, complex disease areas. Oncology consistently commands the largest segment of the outsourced services, reflecting the high volume and complexity of cancer research, which often involves intricate protocols, novel biomarkers, and advanced trial designs....
0 Yorumlar
0 hisse senetleri
1649 Views